Life Sciences Group

Michael Beauvais has over 12 years of experience representing clients in the healthcare services, health information technology (HIT), medical device, biotechnology, specialty pharmaceutical and ...

Alan, managing partner of the DC office, has advised clients on issues involving pharmaceutical marketing and promotion for more than 25 years. Alan counsels clients and represents them at the FDA ...

Al provides advice to a variety of life sciences and health care clients on legislative, regulatory and corporate matters. The focus of Al’s practice is FDA regulation of pharmaceuticals, ...

John Chesley has been a member of the Health Care Group at Ropes & Gray since 1985. For over 20 years he has focused on meeting the needs of clients in complex transactions and challenging ...

Chris Comeau focuses his practice on representing financial investors and public companies in connection with public and private merger and acquisition and minority investment transactions. The ...

Geoff has extensive experience representing biotechnology, biomedical, medical device and pharmaceutical companies. Geoff’s work includes numerous corporate partnering and licensing transactions ...

Jim works with multi-national organizations in High Technology, Life Sciences and Private Equity industries to help protect and achieve their business goals. In serving them, Jim often draws on ...

Scott advises clients in the private equity, life sciences and technology industries on a variety of corporate and transactional matters including mergers and acquisitions, corporate financing ...

Michael represents organizations and individuals in a wide variety of investigations and enforcement proceedings brought by federal, state and foreign government agencies. His practice focuses on ...

Joel represents institutional investors and private and public companies in the full range of their business and strategic development initiatives. As a former vice-president and general counsel ...

Susan, a partner in the Life Sciences Practice Group, focuses her practice on advising pharmaceutical, biotech and medical device companies on licensing, collaboration and research agreements, ...

Jane works with a wide range of biotechnology and pharmaceutical clients on strategic portfolio development and management, world-wide patent prosecution, opinions, search-based analyses including ...

For over 30 years, Jim has focused his practice on the worldwide procurement, defense and enforcement of patents in the biotechnology, biopharmaceutical, pharmaceutical and chemical industries. He ...

David Halstead works with clients in the biotechnology, chemical, and pharmaceutical industries on a wide range of intellectual property issues. He helps clients obtain robust and enforceable ...

Ed provides intellectual property advice, legal opinions and strategies for securing patents, trademarks and copyrights to a broad range of clients.

Ed works with a number of clients, ...

Paul is co-head of the firm’s Securities and Public Companies practice. Paul represents public companies in business combinations and securities offerings, regularly advising clients on tender ...

Bill represents a wide variety of health care and life science clients on state and federal regulatory and corporate matters. Bill's clients include academic medical centers and faculty practice ...

Geoffrey Leonard, Managing Partner of the San Francisco office, focuses his practice on the representation of technology companies, including life sciences companies, and has considerable ...

Greg Levine, co-chair of the Life Sciences Practice Group, focuses his practice on FDA regulation of pharmaceuticals, biotechnology and medical devices. He also counsels his pharmaceutical and ...

Denise Loring has extensive experience as lead counsel in high-stakes patent litigation, in both U.S. federal and international courts. Denise’s practice has included a variety of technologies, ...

With almost 30 years of regulatory, legislative and litigation experience in Washington, D.C., Bruce Manheim brings a multidisciplinary approach to the complex array of scientific and legal issues ...

David advises a wide range of companies, investors, and institutions in all manner of transactions involving intellectual property, including technology licensing, product development ...

Joan McPhee focuses her practice on white collar criminal defense and complex civil litigation. Joan has over two decades of experience representing multi-national and domestic corporations, ...

Arthur Mok is a partner in our Private Equity and Life Sciences group. Arthur concentrates his practice on cross-border mergers and ...

Patrick O’Brien is co-head of the firm’s Securities and Public Companies practice. He concentrates his practice on the life science, healthcare and technology practice areas representing public ...

Brien O'Connor, a partner in the Boston office, has represented numerous well-known corporations, as well as individuals, in white-collar criminal cases and investigations and other government ...

Marc Rubenstein, co-chair of the Life Sciences Practice Group, focuses on representing clients in the biotechnology, medical device and pharmaceutical industries in a wide variety of transactions, ...

Harry Rubin is the Co-Leader of the firm's International Practice Group. He is a globally recognized authority on intellectual property transactions, technology commercialization, strategic ...

David Saul focuses his practice on the representation of life science companies, including those in the medical device, specialty pharmaceutical and biotechnology fields. David advises his clients ...

Michael F. Sexton focuses his practice on representing pharmaceutical manufacturers, medical device companies, biotechnology companies and life sciences venture capital firms in connection with ...

Anita is co-head of Ropes & Gray's Intellectual Property Rights Management Practice Group and has over 20 years of experience in intellectual property law as a lawyer and as a Patent Examiner ...

Steve Wilcox focuses his practice on mergers and acquisitions, corporate financing transactions (including public offerings and venture capital investments) and licensing ...